Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
NCT02684409
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Migraine
Interventions
DRUG:
PROT-CL-NP101-015.01
Sponsor
NuPathe Inc.